Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
A RotondoD Goldman

Abstract

We recently reported two naturally occurring polymorphisms of the human serotonin1A (5-HT1A) receptor: glycine22-->serine (Ser22) and isoleucine28-->valine (Val28) in the putative aminoterminal domain of the receptor. To investigate the regulatory properties of these variants, the wild type (WT) and variant 5-HT1A receptors were stably expressed in CHO-K1 cells. WT, Ser22, and Val28 displayed similar high-affinity binding to [3H]-8-OH-DPAT. Competition experiments with 5-HT1A agonists and antagonists demonstrated similar pharmacological profiles. Receptor agonist-promoted down-regulation was tested by exposure to 100 mumol/L 8-OH-DPAT. After 24-h exposure, WT and Val28 underwent 59.3 +/- 3.9% and 59.5 +/- 1.4% reduction in receptor density respectively, whereas the degree of down-regulation was significantly lower for Ser22 (21.4 +/- 4.2%). Cell treatment for 24 h with 100 mumol/L 8-OH-DPAT reduced the 5-HT-induced inhibition of cAMP accumulation by 24.9 +/- 5.1% for WT and 16.4 +/- 0.8% for Val28, but only by 4.8 +/- 3% for Ser22. We conclude that the Ser22 variant is capable of attenuating agonist-mediated receptor down-regulation and desensitization.

Citations

Mar 24, 2004·Biochemical Pharmacology·Andria L Del TrediciDavid M Weiner
Jan 3, 2001·European Journal of Pharmacology·J Veenstra-VanderWeeleE H Cook
Oct 25, 2003·Cellular Signalling·Joshua G Lisinicchia, Val J Watts
May 3, 2005·Pharmacogenetics and Genomics·Michael BrüssManfred Göthert
Feb 3, 1999·Annals of the New York Academy of Sciences·M GöthertM M Nöthen
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·B K RanaP A Insel
Jan 3, 2001·European Journal of Pharmacology·Y KawanishiT Suzuki
Jun 16, 2007·Molecular Diagnosis & Therapy·Gary M LevinWilliam J Millard
Nov 12, 2009·Pharmacological Reports : PR·Sandra CombrinkHeinz Bönisch
Feb 25, 2003·American Journal of Medical Genetics. Part a·Debra E Weese-MayerMary L Marazita
Oct 19, 2005·British Journal of Pharmacology·Cathérine DelesalleRomain A Lefebvre
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Chih-Min Tang, Paul A Insel
Dec 1, 2007·The International Journal of Neuropsychopharmacology·Antonio DragoAlessandro Serretti
May 17, 2000·American Journal of Medical Genetics·S CichonP Propping
Nov 10, 2004·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Paul R Albert, Sylvie Lemonde
Dec 8, 2000·Biochemical Pharmacology·P J Pauwels
Jul 22, 2008·Neuropharmacology·Brice Le FrançoisPaul R Albert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.